{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:06:03Z","timestamp":1772478363816,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003486","name":"Hellenic Rheumatology Society and Professional Organization for Rheumatologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003486","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12891-016-1072-1","type":"journal-article","created":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T23:03:31Z","timestamp":1463439811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clopidogrel treatment may associate with worsening of endothelial function and development of new digital ulcers in patients with systemic sclerosis: results from an open label, proof of concept study"],"prefix":"10.1186","volume":"17","author":[{"given":"Konstantinos","family":"Ntelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Gkizas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Filippopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Periclis","family":"Davlouros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"Andonopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Daoussis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"issue":"2","key":"1072_CR1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/rheumatology\/kep093","volume":"49","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Liossis S-NC, Tsamandas AC, Kalogeropoulou C, Kazantzi A, Sirinian C, et al. Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study. Rheumatology (Oxford). 2010;49(2):271\u201380.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1072_CR2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11926-013-0326-2","volume":"15","author":"K Naraghi","year":"2013","unstructured":"Naraghi K, van Laar JM. Update on stem cell transplantation for systemic sclerosis: recent trial results. Curr Rheumatol Rep. 2013;15(5):326.","journal-title":"Curr Rheumatol Rep"},{"key":"1072_CR3","first-page":"S17","volume":"30","author":"D Daoussis","year":"2012","unstructured":"Daoussis D, Liossis S-NC, Tsamandas AC, Kalogeropoulou C, Paliogianni F, Sirinian C, et al. Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis. Clin Exp Rheumatol. 2012;30:S17\u201322.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"1072_CR4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.semarthrit.2009.09.003","volume":"40","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Liossis S-NC, Tsamandas AC, Kalogeropoulou C, Kazantzi A, Korfiatis P, et al. Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature. Semin Arthritis Rheum. 2010;40(2):127\u201336.","journal-title":"Semin Arthritis Rheum"},{"issue":"2-3","key":"1072_CR5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12016-008-8114-x","volume":"36","author":"VKK Bournia","year":"2009","unstructured":"Bournia VKK, Vlachoyiannopoulos PG, Selmi C, Moutsopoulos HM, Gershwin ME. Recent advances in the treatment of systemic sclerosis. Clin Rev Allergy Immunol. 2009;36(2-3):176\u2013200.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1072_CR6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","volume":"6","author":"TR Katsumoto","year":"2011","unstructured":"Katsumoto TR, Whitfield ML, Connolly MK. The pathogenesis of systemic sclerosis. Annu Rev Pathol Ann Rev. 2011;6:509\u201337.","journal-title":"Annu Rev Pathol Ann Rev"},{"issue":"9","key":"1072_CR7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nrrheum.2012.118","volume":"8","author":"E Boilard","year":"2012","unstructured":"Boilard E, Blanco P, Nigrovic PA. Platelets: active players in the pathogenesis of arthritis and SLE. Nat Rev Rheumatol. 2012;8(9):534\u201342.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1072_CR8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2036.1997.153328000.x","volume":"11","author":"CE COLLINS","year":"1997","unstructured":"COLLINS CE, RAMPTON DS. Review article: platelets in inflammatory bowel disease- pathogenetic role and therapeutic implications. Aliment Pharmacol Ther. 1997;11(2):237\u201347.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"1072_CR9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/BOR.0b013e3282eeb3a4","volume":"19","author":"AE Postlethwaite","year":"2007","unstructured":"Postlethwaite AE, Chiang TM. Platelet contributions to the pathogenesis of systemic sclerosis. Curr Opin Rheumatol. 2007;19(6):574\u20139.","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"1072_CR10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7150\/ijms.6.168","volume":"6","author":"A Tokumura","year":"2009","unstructured":"Tokumura A, Carbone LD, Yoshioka Y, Morishige J, Kikuchi M, Postlethwaite A, et al. Elevated serum levels of arachidonoyl-lysophosphatidic acid and sphingosine 1-phosphate in systemic sclerosis. Int J Med Sci. 2009;6(4):168\u201376.","journal-title":"Int J Med Sci"},{"issue":"12","key":"1072_CR11","first-page":"2565","volume":"29","author":"RF Macko","year":"2002","unstructured":"Macko RF, Gelber AC, Young BA, Lowitt MH, White B, Wigley FM, et al. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation. J Rheumatol. 2002;29(12):2565\u201370.","journal-title":"J Rheumatol"},{"issue":"12","key":"1072_CR12","first-page":"1833","volume":"18","author":"J Lima","year":"1991","unstructured":"Lima J, Fonollosa V, Fern\u00e1ndez-Cortijo J, Ordi J, Cuenca R, Khamashta MA, et al. Platelet activation, endothelial cell dysfunction in the absence of anticardiolipin antibodies in systemic sclerosis. J Rheumatol. 1991;18(12):1833\u20136.","journal-title":"J Rheumatol"},{"issue":"2","key":"1072_CR13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/ard.55.2.122","volume":"55","author":"AL Herrick","year":"1996","unstructured":"Herrick AL, Illingworth K, Blann A, Hay CR, Hollis S, Jayson MI. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud\u2019s phenomenon and systemic sclerosis. Ann Rheum Dis. 1996;55(2):122\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1072_CR14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20101629","volume":"208","author":"C Dees","year":"2011","unstructured":"Dees C, Akhmetshina A, Zerr P, Reich N, Palumbo K, Horn A, et al. Platelet-derived serotonin links vascular disease and tissue fibrosis. J Exp Med. 2011;208(5):961\u201372.","journal-title":"J Exp Med"},{"issue":"3","key":"1072_CR15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0167-5273(88)90238-0","volume":"19","author":"ML Biondi","year":"1988","unstructured":"Biondi ML, Marasini B, Bianchi E, Agostoni A. Plasma free and intraplatelet serotonin in patients with Raynaud\u2019s phenomenon. Int J Cardiol. 1988;19(3):335\u20139.","journal-title":"Int J Cardiol"},{"issue":"10","key":"1072_CR16","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.ATV.20.10.2233","volume":"20","author":"A Kereveur","year":"2000","unstructured":"Kereveur A, Callebert J, Humbert M, Herve P, Simonneau G, Launay J-M, et al. High Plasma Serotonin Levels in Primary Pulmonary Hypertension: Effect of Long-Term Epoprostenol (Prostacyclin) Therapy. Arterioscler Thromb Vasc Biol. 2000;20(10):2233\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"1072_CR17","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.1780271009","volume":"27","author":"VL Beckett","year":"1984","unstructured":"Beckett VL, Conn DL, Fuster V, Osmundson PJ, Strong CG, Chao EY, et al. Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin. Arthritis Rheum. 1984;27(10):1137\u201343.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1072_CR18","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1072_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation. Ann Intern Med. 1999;130(6):461.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1072_CR20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/art.21084","volume":"53","author":"SR Johnson","year":"2005","unstructured":"Johnson SR, Hawker GA, Davis AM. The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties. Arthritis Rheum. 2005;53(2):256\u201362.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1072_CR21","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22(7):1281\u20135.","journal-title":"J Rheumatol"},{"issue":"9","key":"1072_CR22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/ard.62.9.901","volume":"62","author":"G Valentini","year":"2003","unstructured":"Valentini G. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis. 2003;62(9):901\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1072_CR23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0006-291X(92)91234-H","volume":"187","author":"R Pigott","year":"1992","unstructured":"Pigott R, Dillon LP, Hemingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun. 1992;187(2):584\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"1072_CR24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2008.11.030","volume":"53","author":"D Sibbing","year":"2009","unstructured":"Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Sch\u00f6mig A, et al. Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis. J Am Coll Cardiol. 2009;53(10):849\u201356.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1072_CR25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","volume":"56","author":"L Bonello","year":"2010","unstructured":"Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010;56(12):919\u201333.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1072_CR26","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jacc.2005.01.034","volume":"45","author":"TA Nguyen","year":"2005","unstructured":"Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol. 2005;45(8):1157\u201364.","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"1072_CR27","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","volume":"107","author":"PA Gurbel","year":"2003","unstructured":"Gurbel PA, Bliden KP, Hiatt BL, O\u2019Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation. 2003;107(23):2908\u201313.","journal-title":"Circulation"},{"issue":"20","key":"1072_CR28","first-page":"761","volume":"95","author":"R Cuenca","year":"1990","unstructured":"Cuenca R, Fern\u00e1ndez-Cortijo J, Lima J, Fonollosa V, Sime\u00f3n CP, Pico M, et al. [Platelet function study in primary Raynaud\u2019s phenomenon and Raynaud's phenomenon associated with scleroderma]. Med Clin (Barc). 1990;95(20):761\u20133.","journal-title":"Med Clin (Barc)"},{"issue":"2","key":"1072_CR29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jcp.37.2.182","volume":"37","author":"RA Hutton","year":"1984","unstructured":"Hutton RA, Mikhailidis DP, Bernstein RM, Jeremy JY, Hughes GR, Dandona P. Assessment of platelet function in patients with Raynaud\u2019s syndrome. J Clin Pathol. 1984;37(2):182\u20137.","journal-title":"J Clin Pathol"},{"issue":"8","key":"1072_CR30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/ard.50.8.567","volume":"50","author":"JE Price","year":"1991","unstructured":"Price JE, Klimiuk PS, Jayson MI. In vitro platelet aggregability studies: lack of evidence for platelet hyperactivity in systemic sclerosis. Ann Rheum Dis. 1991;50(8):567\u201371.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1072_CR31","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1111\/j.1538-7836.2011.04531.x","volume":"9","author":"D Alexopoulos","year":"2011","unstructured":"Alexopoulos D, Panagiotou A, Xanthopoulou I, Komninakis D, Kassimis G, Davlouros P, et al. Antiplatelet effects of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on-treatment platelet reactivity. J Thromb Haemost. 2011;9(12):2379\u201385.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"1072_CR32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.yjmcc.2008.12.019","volume":"46","author":"S Yabanoglu","year":"2009","unstructured":"Yabanoglu S, Akkiki M, Seguelas M-H, Mialet-Perez J, Parini A, Pizzinat N. Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors. J Mol Cell Cardiol. 2009;46(4):518\u201325.","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"1072_CR33","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/cncr.25049","volume":"116","author":"B Svejda","year":"2010","unstructured":"Svejda B, Kidd M, Giovinazzo F, Eltawil K, Gustafsson BI, Pfragner R, et al. The 5-HT(2B) receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment. Cancer. 2010;116(12):2902\u201312.","journal-title":"Cancer"},{"issue":"7","key":"1072_CR34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/ard.48.7.586","volume":"48","author":"PS Klimiuk","year":"1989","unstructured":"Klimiuk PS, Grennan A, Weinkove C, Jayson MI. Platelet serotonin in systemic sclerosis. Ann Rheum Dis. 1989;48(7):586\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1072_CR35","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCRESAHA.107.158410","volume":"101","author":"E Gkaliagkousi","year":"2007","unstructured":"Gkaliagkousi E, Ritter J, Ferro A. Platelet-derived nitric oxide signaling and regulation. Circ Res. 2007;101(7):654\u201362.","journal-title":"Circ Res"},{"issue":"5","key":"1072_CR36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00424-002-0978-7","volume":"445","author":"TMC Brunini","year":"2003","unstructured":"Brunini TMC, Yaqoob MM, Novaes Malagris LE, Ellory JC, Mann GE, Mendes Ribeiro AC. Increased nitric oxide synthesis in uraemic platelets is dependent on L-arginine transport via system y(+)L. Pflugers Arch. 2003;445(5):547\u201350.","journal-title":"Pflugers Arch"},{"key":"1072_CR37","doi-asserted-by":"crossref","unstructured":"Joshi N, Kopec AK, O\u2019Brien KM, Towery KL, Cline-Fedewa H, Williams KJ, et al. Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice. J Thromb Haemost. 2015;13(1):57\u201371.","DOI":"10.1111\/jth.12770"},{"issue":"2","key":"1072_CR38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/hep.21516","volume":"45","author":"A Nocito","year":"2007","unstructured":"Nocito A, Georgiev P, Dahm F, Jochum W, Bader M, Graf R, et al. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology. 2007;45(2):369\u201376.","journal-title":"Hepatology"},{"issue":"6","key":"1072_CR39","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1152\/japplphysiol.01362.2009","volume":"108","author":"LA Holowatz","year":"2010","unstructured":"Holowatz LA, Jennings JD, Lang JA, Kenney WL. Systemic low-dose aspirin and clopidogrel independently attenuate reflex cutaneous vasodilation in middle-aged humans. J Appl Physiol. 2010;108(6):1575\u201381.","journal-title":"J Appl Physiol"},{"issue":"11","key":"1072_CR40","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.amjmed.2013.06.025","volume":"126","author":"S-Y Chu","year":"2013","unstructured":"Chu S-Y, Chen Y-J, Liu C-J, Tseng W-C, Lin M-W, Hwang C-Y, et al. Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study. Am J Med. 2013;126(11):982\u20138.","journal-title":"Am J Med"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1072-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T10:27:16Z","timestamp":1526639236000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-016-1072-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1072"],"URL":"https:\/\/doi.org\/10.1186\/s12891-016-1072-1","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]},"article-number":"213"}}